Home LungLife AI

LungLife AI

In operation
IPO
Provider of Early Cancer Detection Solutions
Basic
Enterprise Profile

Basic Information

LungLife AI is a molecular diagnostics company dedicated to the early detection and treatment of cancer. It utilizes machine learning and artificial intelligence to enable life-saving early diagnosis of lung cancer. The company focuses on transforming cancer diagnosis and management through artificial intelligence (AI), facilitating the molecular analysis of cancer biomarkers in blood.
LungLife AI, Inc.
California,United States of America
15~50 people
January 01, 2008
--

Enterprise Profile

Industrial Sector
Medical Device R&D and Design
Technology
Liquid Biopsy Molecular Diagnostics Artificial Intelligence Targeted Technology
Concept
Lung Cancer
Application Scenarios
Medical Device Consumables